PET in Prostate and Bladder Tumors
Seminars in Nuclear Medicine, 06/08/2012
Lee ST et al. – New positron emission tomography (PET) tracers are showing promise in the staging and biological characterization of prostate cancer, which can assist with therapeutic decision making in patients undergoing radiotherapy of primary disease, and in the assessment of metastatic disease.



